...In September, Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP) reported additional data from 6 patients with moderate to severe bullous...
...QOL) score. Bertilimumab is a human mAb against chemokine CC motif ligand 11 (CCL11; eotaxin-1). Immune Pharmaceuticals...
...degeneration (AMD). AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. iCo Therapeutics Inc. (TSX-V:ICO; OTCQX:ICOTF), Vancouver, B.C. Immune Pharmaceuticals Inc....

...On Oct. 19, immunology and inflammation company Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP) raised $18 million through the sale...
...preferred stock and 982 seven-year warrants to purchase a share of common stock at $1.10. Immune Pharmaceuticals Inc....

...and movement disorders at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). Autoimmune and cancer company Immune Pharmaceuticals Inc....

...EU and Israel for maintenance of remission and prevention of relapse in patients with AML. Immune Pharmaceuticals Inc....
...OS) and circulating CD8+ and CD4+ T cells Status: Phase I/II started Milestone: NA Alex Himes Ceplene histamine dihydrochloride Immune Pharmaceuticals Inc. histamine...

...the patients' oral prednisone dose was tapered down to ≤10 mg/day. Based on the data, Immune Pharmaceuticals...
...off of chronic steroids. Bullous pemphigoid is a rare autoimmune blistering disease of the skin. Immune Pharmaceuticals...
...ocular allergies and wet age-related macular degeneration (AMD). iCo Therapeutics Inc. (TSX-V:ICO; OTCQX:ICOTF), Vancouver, B.C. Immune Pharmaceuticals Inc....

...to inquiries. SATT Sud-Est, Marseille, France Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP), New York, N.Y. Business: Cancer, Antibodies Alex Himes Immune Pharmaceuticals Inc. Interleukin-8...

...up to an additional $10 million from the investor. Immune Pharmaceuticals Inc. (NASDAQ:IMNP; SSE:IMNP), New York, N.Y. Alex Himes Immune Pharmaceuticals Inc....

...Shares: TBD Price prior: $0.34 Shares outstanding prior: 101.6 million Investor: Novel Pain Therapeutics Note: Immune Pharmaceuticals...

...models to treat AD and other age-related disorders. McCracken would not disclose a development timeline. Immune Pharmaceuticals...
...Carlos, Calif. Grifols S.A. (Madrid:GRF; NASDAQ:GRFS), Barcelona, Spain iCo Therapeutics Inc. (TSX-V:ICO; OTCQX:ICOTF), Vancouver, B.C. Immune Pharmaceuticals Inc....